GeneDx Holdings Corp. (WGS)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$481.5M
Stockholders' Equity
$244.2M
Cash & Equivalents
$60.3M
Long-Term Debt
$100.0M

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, GeneDx Holdings Corp. reported revenue of $114.4M, net income of -$17.7M, and total assets of $481.5M. Every figure below is taken directly from GeneDx Holdings Corp.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2019–FY2025 · as reported

$427.5M-$60.7M-$549.0M
FY2019FY2021FY2023FY2025
Revenue$427.5MNet income-$21.0M
FY2019 revenue
$196.2M
FY2025 revenue
$427.5M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$427.5M-$21.0M
FY2024$305.4M-$52.3M
FY2023$202.6M-$175.8M
FY2022$234.7M-$549.0M
FY2021$212.2M-$245.4M
FY2020$179.3M-$241.3M
FY2019$196.2M-$29.7M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KAug 3, 2026on EDGAR ↗
10-QAug 3, 2026on EDGAR ↗
8-KJun 23, 2026on EDGAR ↗
8-KJun 16, 2026on EDGAR ↗
8-KMay 4, 2026on EDGAR ↗
10-QMay 4, 2026on EDGAR ↗
DEF 14AApr 30, 2026on EDGAR ↗
8-KMar 2, 2026on EDGAR ↗
8-KFeb 23, 2026on EDGAR ↗
10-KFeb 23, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$481.5Msource ↗
Stockholders’ Equity$244.2Msource ↗
Cash & Equivalents$60.3Msource ↗
Long-Term Debt$100.0Msource ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$114.4Msource ↗
Net Income-$17.7Msource ↗
Operating Income-$17.5Msource ↗
Gross Profit$78.2Msource ↗
Cost of Revenue$36.2Msource ↗
R&D Expense$19.7Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.60source ↗
EPS (basic)$-0.60source ↗
Shares Outstanding29.8Msource ↗
Cash from Operations-$29.0Msource ↗
Cash from Financing$1.0Msource ↗
Cash from Investing-$5.6Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
24
Sells
22
Net shares
+2.2M

Restatement history

Point-in-time

9 of 245 annual fact-keys were materially restated between filings: what GeneDx Holdings Corp. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches WGS’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/WGS

MCP tool: get_sec_fundamentals ticker=WGS

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/WGS/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=WGS as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/WGS/history

MCP tool: get_fundamentals_history ticker=WGS

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/WGS

MCP tool: get_financial_health ticker=WGS

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.